Compass Therapeutics Inc.

NASDAQ: CMPX · Real-Time Price · USD
2.98
0.03 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.97
-0.34%
After-hours: Aug 15, 2025, 05:01 PM EDT

Compass Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-62.03M -55.22M -49.38M -47.76M -47.24M -45.44M -42.49M -40.67M -42.68M -39.9M -39.23M -40.61M -34.61M -81.92M -82.18M -77.59M -80.76M -30.52M
Depreciation & Amortization
962K 1.65M 1.75M 1.86M 1.86M 1.87M 1.89M 1.91M 1.93M 1.95M 1.9M 1.82M 1.74M 1.65M 1.62M 2.3M 2.33M 2.35M
Stock-Based Compensation
9.74M 9.07M 8.56M 7.92M 7.35M 6.86M 6.12M 5.54M 5.21M 5.02M 5.33M 5.49M 5.19M 4.66M 4.03M 3.89M 5.44M 4.72M
Other Working Capital
4.72M 847K -2.3M -6.54M -2.65M -2.28M 1.93M 3.34M 5.44M 657K -3.78M 3.48M 1.07M 3.78M 6.44M -1.09M -2.18M -1.42M
Other Non-Cash Items
-57K -1.25M 4.51M 4.72M 4.22M 3.91M -2.47M -3.02M -2.54M -1.46M 2.18M 2.8M 3.11M 3.08M 41K 53K 62K -971K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 33K 2K 50.62M 50.58M 50.82M 50.85M 473K
Change in Working Capital
6.13M 1.57M -4.14M -7.88M -2.19M -2.55M -2.91M -2.66M -5.84M -4.02M -1.26M 5.38M 6.96M 2.97M 6.25M -1.04M -3.2M -700K
Operating Cash Flow
-45.25M -44.17M -44.85M -48.05M -42.92M -42.28M -40.62M -38.91M -43.92M -38.41M -34.13M -28.15M -20.66M -22M -19.67M -21.57M -25.29M -24.65M
Capital Expenditures
-62K -62K -44K -53K -19K -30K -30K -75K -92K -212K -406K -1.13M -1.47M -1.63M -1.57M -874K -514K -222K
Cash Acquisitions
n/a n/a n/a 16.4K -656 n/a n/a 353.6K 369.45K 543.79K 544.79K 175.79K 177K 2K 116K 115K 115K 115K
Purchase of Investments
-73.21M -71.11M -88.16M -123.38M -135.4M -142.38M -155.42M -193.13M -187.3M -255.04M -200.12M -117.33M -105.78M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
122.89M 133.63M 134.97M 161.15M 161.17M 161M 182.41M 167.21M 145.53M 108.14M 48.95M 12.76M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -4.1K 2.22K 19.28K 18.63K 27K -349.33K -365.18K 4.48K 1.21K 372.21K 371K -316K -202K -114K -114K 259K
Investing Cash Flow
49.62M 62.46M 46.77M 37.72M 25.75M 18.6M 26.96M -26M -41.86M -146.74M -151.2M -105.33M -106.88M -1.95M -1.77M -988K -628K 37K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -136 -295 -295 -295 -159 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-911K -910K -231K -296K -293.98K -291.95K -155.91K -476.91K -476.92K -479.95K -480K -281K -281K -281K -2.16M -60.48M -61.28M -6.32M
Financial Cash Flow
-911K -910K 17.34M 17.27M 17.3M 20.33M 2.94M 78.84M 78.83M 75.8M 75.76M 124.24M 122.36M 120.49M 118.61M -7.5M -8.3M 46.66M
Net Cash Flow
3.45M 17.37M 19.25M 6.94M 126K -3.35M -10.72M 13.95M -6.96M -109.35M -109.57M -9.24M -5.18M 96.53M 97.17M -30.06M -34.22M 22.05M
Free Cash Flow
-45.31M -44.24M -44.9M -48.1M -42.94M -42.31M -40.65M -38.98M -44.02M -38.62M -34.53M -29.28M -22.13M -23.64M -21.23M -22.45M -25.8M -24.87M